Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin status

活体成像技术根据Merlin状态指导胰腺癌精准医疗中FAK介导的启动

阅读:8
作者:Kendelle J Murphy, Daniel A Reed, Claire Vennin, James R W Conway, Max Nobis, Julia X Yin, Cecilia R Chambers, Brooke A Pereira, Victoria Lee, Elysse C Filipe, Michael Trpceski, Shona Ritchie, Morghan C Lucas, Sean C Warren, Joanna N Skhinas, Astrid Magenau, Xanthe L Metcalf, Janett Stoehr, Gretel M

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a highly metastatic, chemoresistant malignancy and is characterized by a dense, desmoplastic stroma that modulates PDAC progression. Here, we visualized transient manipulation of focal adhesion kinase (FAK), which integrates bidirectional cell-environment signaling, using intravital fluorescence lifetime imaging microscopy of the FAK-based Förster resonance energy transfer biosensor in mouse and patient-derived PDAC models. Parallel real-time quantification of the FUCCI cell cycle reporter guided us to improve PDAC response to standard-of-care chemotherapy at primary and secondary sites. Critically, micropatterned pillar plates and stiffness-tunable matrices were used to pinpoint the contribution of environmental cues to chemosensitization, while fluid flow–induced shear stress assessment, patient-derived matrices, and personalized in vivo models allowed us to deconstruct how FAK inhibition can reduce PDAC spread. Last, stratification of PDAC patient samples via Merlin status revealed a patient subset with poor prognosis that are likely to respond to FAK priming before chemotherapy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。